甲基化物及其对降氧平衡和行为的影响
George Jîtcă1, Ingrid Evelin Mehelean2, Ana Natalia Maier2
1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.
Journal of xenobiotics
|October 28, 2025
概括
甲基化物 (MPH) 用于ADHD具有非医疗用途的风险,导致线粒体问题和神经毒性. 肠道微生物组和法医分析为更安全的使用和滥用监测提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 法医毒理学 法医毒理学
背景情况:
- 甲基化物 (MPH) 和甲基化物是ADHD的主要治疗方法.
- 非医疗用途存在临床和毒理方面的担忧.
- MPH的目标是多巴胺 (DAT) 和北上腺素 (NET) 运输体.
研究的目的:
- 调查MPH的治疗效果与毒理学风险的对比.
- 探索肠-大脑轴对MPH结果的影响.
- 审查检测MPH滥用的法医方法.
主要方法:
- 关于MPH药理学,毒理学和肠-大脑相互作用的文献综述.
- 分析目前用于MPH检测的法医技术 (例如LC-MS/MS,头发分析).
- 检查与MPH暴露相关的线粒体功能和ROS产生的研究.
主要成果:
- MPH的机制涉及阻断DAT和NET,增加类甲醇胺.
- 长期/滥用MPH使用与线粒体功能障碍,生物能干扰和ROS产生有关.
- 肠道微生物组的组成影响MPH代谢,氧化应激和神经炎症.
- 先进的法医方法改善了MPH滥用监控.
结论:
- MPH具有狭窄的治疗窗口,平衡好处和风险.
- 肠-大脑轴呈现了潜在的干预目标 (饮食,益生菌).
- 需要进一步研究人类纵向研究,生物标志物和针对线粒体的治疗方法,以确保MPH的安全性.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
736
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
736
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
Redox Reactions
876
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
876
Mania and Antimanic Drugs: Overview
542
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
542
Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K


